[go: up one dir, main page]

PE20010041A1 - DERIVATIVES OF 1-AMINOETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS - Google Patents

DERIVATIVES OF 1-AMINOETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Info

Publication number
PE20010041A1
PE20010041A1 PE2000000344A PE0003442000A PE20010041A1 PE 20010041 A1 PE20010041 A1 PE 20010041A1 PE 2000000344 A PE2000000344 A PE 2000000344A PE 0003442000 A PE0003442000 A PE 0003442000A PE 20010041 A1 PE20010041 A1 PE 20010041A1
Authority
PE
Peru
Prior art keywords
alkyl
aminoethylindol
derivatives
fluoroalkyl
hydroxyethyl
Prior art date
Application number
PE2000000344A
Other languages
Spanish (es)
Inventor
Philippe R Bovy
Patrick Mougenot
Philippo Christophe
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PE20010041A1 publication Critical patent/PE20010041A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE 1-AMINOETILINDOL DE FORMULA I, DONDE: A ES H, HALOGENO, HIDROXI; B Y D SON H, ALQUILO C1-C3; R1 ES H, ALQUILO C1-C4, FLUOROALQUILO C1-C2, PERFLUOROALQUILO C1-C2; R2 ES H, HALOGENO, ALQUILO C1-C6, CICLOALQUILO C3-C6, FLUOROALQUILO C1-C2, PERFLUOROALQUILO, FENILO; R3 Y R4 SON H, HALOGENO, ALQUILO C1-C6; R5 Y R6 SON H, ALQUILO C1-C6, FLUOROALQUILO C1-C2; R5 Y R6 JUNTOS SON ALQUILENO C2-C7. SON COMPUESTOS PREFERIDOS 2-METILINDOL-4-(1-DIETILAMINO-2-HIDROXIETIL)INDOL, 1(N)-METIL-2-ETILINDOL-4-(1-DIETILAMINO-2-HIDROXIETIL)INDOL, 1(N)-METIL-2-FENIL-4-(1-DIETILAMINO-2-HIDROXIETIL)INDOL, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION. LOS DERIVADOS DE 1-AMINOETILINDOL DE FORMULA I TIENEN ACCION CONTRACTIL SOBRE LOS MUSCULOS LISOS URETRALES Y ARTERIALES Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE INCONTINENCIA URINARIA DE ESFUERZO, INSUFICIENCIA VENOSA, MIGRANA, TRASTORNOS GASTROINTESTINALESREFERS TO 1-AMINOETHYLINDOL DERIVATIVES OF FORMULA I, WHERE: A IS H, HALOGEN, HYDROXY; B AND D ARE H, C1-C3 ALKYL; R1 IS H, C1-C4 ALKYL, C1-C2 FLUOROALKYL, C1-C2 PERFLUOROALKYL; R2 IS H, HALOGEN, C1-C6 ALKYL, C3-C6 CYCLOALKYL, C1-C2 FLUOROALKYL, PERFLUOROALKYL, PHENYL; R3 AND R4 ARE H, HALOGEN, C1-C6 ALKYL; R5 AND R6 ARE H, C1-C6 ALKYL, C1-C2 FLUOROALKYL; R5 AND R6 TOGETHER ARE C2-C7 ALKYLENE. PREFERRED COMPOUNDS ARE 2-METHYLINDOL-4- (1-DIETHYLINDOL-2-HYDROXYETHYL) INDOL, 1 (N) -METHYL-2-ETHYLINDOL-4- (1-DIETHYLINDLE-2-HYDROXYETHYL) INDOLE, 1 (N) -METIL -2-PHENYL-4- (1-DIETHYLAMINE-2-HYDROXYETHYL) INDOL, AMONG OTHERS. IT ALSO REFERS TO A PROCEDURE FOR PREPARATION. THE 1-AMINOETHYLINDOL DERIVATIVES OF FORMULA I HAVE CONTRACTILE ACTION ON THE URETHRAL AND ARTERIAL SMOOTH MUSCLES AND MAY BE USEFUL FOR THE TREATMENT OF URINARY STRESS INCONTINENCE, VENOUS INSUFFICIENCY, MIGRANE, GASTROESTINAL DISORDERS

PE2000000344A 1999-04-13 2000-04-13 DERIVATIVES OF 1-AMINOETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS PE20010041A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904577A FR2792316B1 (en) 1999-04-13 1999-04-13 1-AMINOETHYLINDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
PE20010041A1 true PE20010041A1 (en) 2001-04-12

Family

ID=9544316

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000344A PE20010041A1 (en) 1999-04-13 2000-04-13 DERIVATIVES OF 1-AMINOETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Country Status (7)

Country Link
AR (1) AR023451A1 (en)
AU (1) AU3971400A (en)
CO (1) CO5180549A1 (en)
FR (1) FR2792316B1 (en)
PE (1) PE20010041A1 (en)
UY (1) UY26102A1 (en)
WO (1) WO2000061554A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR077405A1 (en) 2009-07-10 2011-08-24 Sanofi Aventis DERIVATIVES OF INDOL INHIBITORS OF HSP90, COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME FOR THE TREATMENT OF CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752839B1 (en) * 1996-08-29 1998-10-09 Synthelabo BENZOFURANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2752840A1 (en) * 1996-08-29 1998-03-06 Synthelabo 7-Amino ethyl benzothiophene derivatives

Also Published As

Publication number Publication date
AR023451A1 (en) 2002-09-04
UY26102A1 (en) 2000-10-31
AU3971400A (en) 2000-11-14
FR2792316A1 (en) 2000-10-20
FR2792316B1 (en) 2001-06-22
WO2000061554A1 (en) 2000-10-19
CO5180549A1 (en) 2002-07-30

Similar Documents

Publication Publication Date Title
AR031627A1 (en) GLUCOQUINASA FUSIONED HETEROAROMATIC ACTIVATORS
ATE72436T1 (en) 2-(METHYL(4-PIPERIDINYL)>-1,2,3,4-TETRAHYDRO-9H PYRIDO(3,4-B>INDOLDERIVATES, THEIR PRODUCTION AND THERAPEUTIC USE.
PE20020858A1 (en) INDANIL ACILLATED AMINES
PE20011371A1 (en) DERIVATIVES OF 3- (3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-IL) -EXO-8-AZABICYCLO [3.2.1] OCTANE AS ANTAGONISTS OF CCR5 CHEMOKIN RECEPTORS
PE20020721A1 (en) QUINUCLIDINE DERIVATIVES AS ANTIMUSCARINAL AGENTS M3
DK1920764T3 (en) Fluprostenolisopropyl ester for use in the treatment of glaucoma and ocular hypertension
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
YU66201A (en) Amine derivatives as protease inhibitors
PE44297A1 (en) 3-DIMETHYLAMINE-2-METHYLPHENYLIMINE IMIDAZOLIDINE COMPOUNDS WITH ACTIVITY AS O1L AGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE
CA2481482A1 (en) Tropane derivatives as ccr5 modulators
SE9701144D0 (en) Novel compounds, their use and preparation
PE10897A1 (en) FUSED BENZO COMPOUNDS
MA30756B1 (en) CINNAMOYL-PIPERAZINE DERIVATIVES AND THEIR USE AS ANTAGONISTS BY-1
PE20010402A1 (en) DERIVATIVES OF 1,5-DIHIDROPIRROL-2-ONA SUBSTITUTE
PE20120217A1 (en) DERIVATIVES OF ALKYL-HETEROCYCLES CARBAMATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
ES520860A0 (en) PROCEDURE TO PREPARE THEOPHILINS 7-SUBSTITUTED.
PE20010041A1 (en) DERIVATIVES OF 1-AMINOETHYLINDOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
DE69525633D1 (en) CHINOXALINE DERIVATIVES AND THEIR THERAPEUTIC USE
TR200200969T2 (en) The use of carbonylamino derivatives against CNS disorders
AR037880A1 (en) DERIVATIVES OF BENZODIFURANIMIDAZOLINA AND BENZOFURANIMIDAZOLINA AND ITS USE FOR THE TREATMENT OF GLAUCOMA
DK544689D0 (en) THERAPEUTIC ACTIVE RELATIONS
AU8519601A (en) 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents
MXPA03002914A (en) Hexahydropyrazino `1 2 : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction.
PE20001596A1 (en) MORPHOLIN DERIVATIVES
NZ332029A (en) Sulfonamide substituted chromans, process for their preparation, their use as a medicament and pharmaceutical preparations comprising them

Legal Events

Date Code Title Description
FA Abandonment or withdrawal